Your browser doesn't support javascript.
loading
Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease.
Watt, Stephen; Vasquez, Louella; Walter, Klaudia; Mann, Alice L; Kundu, Kousik; Chen, Lu; Sims, Ying; Ecker, Simone; Burden, Frances; Farrow, Samantha; Farr, Ben; Iotchkova, Valentina; Elding, Heather; Mead, Daniel; Tardaguila, Manuel; Ponstingl, Hannes; Richardson, David; Datta, Avik; Flicek, Paul; Clarke, Laura; Downes, Kate; Pastinen, Tomi; Fraser, Peter; Frontini, Mattia; Javierre, Biola-Maria; Spivakov, Mikhail; Soranzo, Nicole.
Afiliação
  • Watt S; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Vasquez L; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Walter K; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Mann AL; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Kundu K; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Chen L; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Sims Y; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Ecker S; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Burden F; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Laboratory Medicine, West China Second University Hospital, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
  • Farrow S; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Farr B; UCL Cancer Institute, London, UK.
  • Iotchkova V; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Elding H; National Health Service Blood and Transplant (NHSBT), Cambridge, UK.
  • Mead D; Department of Haematology, University of Cambridge, Cambridge, UK.
  • Tardaguila M; National Health Service Blood and Transplant (NHSBT), Cambridge, UK.
  • Ponstingl H; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Richardson D; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Datta A; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
  • Flicek P; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK.
  • Clarke L; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Downes K; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Pastinen T; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Fraser P; Human Genetics, Wellcome Sanger Institute, Genome Campus, Hinxton, UK.
  • Frontini M; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
  • Javierre BM; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
  • Spivakov M; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
  • Soranzo N; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK.
Nat Commun ; 12(1): 2298, 2021 04 16.
Article em En | MEDLINE | ID: mdl-33863903
ABSTRACT
Neutrophils play fundamental roles in innate immune response, shape adaptive immunity, and are a potentially causal cell type underpinning genetic associations with immune system traits and diseases. Here, we profile the binding of myeloid master regulator PU.1 in primary neutrophils across nearly a hundred volunteers. We show that variants associated with differential PU.1 binding underlie genetically-driven differences in cell count and susceptibility to autoimmune and inflammatory diseases. We integrate these results with other multi-individual genomic readouts, revealing coordinated effects of PU.1 binding variants on the local chromatin state, enhancer-promoter contacts and downstream gene expression, and providing a functional interpretation for 27 genes underlying immune traits. Collectively, these results demonstrate the functional role of PU.1 and its target enhancers in neutrophil transcriptional control and immune disease susceptibility.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Transativadores / Regulação da Expressão Gênica / Proteínas Proto-Oncogênicas / Elementos Facilitadores Genéticos / Neutrófilos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Transativadores / Regulação da Expressão Gênica / Proteínas Proto-Oncogênicas / Elementos Facilitadores Genéticos / Neutrófilos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Ano de publicação: 2021 Tipo de documento: Article